Fatheya Alawadi
Overview
Explore the profile of Fatheya Alawadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassanein M, Alawadi F, AlKadhim I, Aly H, Bajawi D, Cinar T, et al.
Diabetes Ther
. 2025 Feb;
PMID: 40016571
Introduction: Oral semaglutide, a glucagon-like peptide 1 receptor agonist, requires administration on an empty stomach with up to 120 mL of water, followed by no intake of food, beverages, or...
2.
Sabbour H, Almahmeed W, Alawadi F, Shehab A, Al Zubaidi A, Bashier A, et al.
Front Endocrinol (Lausanne)
. 2025 Jan;
15():1395630.
PMID: 39835266
Background: The combination of cardiovascular disease and diabetes is a highly prevalent condition in the United Arab Emirates. Development and dissemination of evidence-based regional recommendations for optimal screening, treatment and...
3.
Elsherif I, Jammah A, Ibrahim A, Alawadi F, Sadek I, Rahman A, et al.
Prim Care Diabetes
. 2024 Jul;
18(5):471-478.
PMID: 38955658
Prevalence of diabetes in Arab region has significantly increased, resulting in a significant economic burden on healthcare systems. This surge can be attributed to obesity, rapid urbanization, changing dietary habits,...
4.
Bayoumi R, Farooqi M, Alawadi F, Hassanein M, Osama A, Mukhopadhyay D, et al.
PLoS One
. 2024 May;
19(5):e0304036.
PMID: 38805513
Background: Attempts to subtype, type 2 diabetes (T2D) have mostly focused on newly diagnosed European patients. In this study, our aim was to subtype T2D in a non-white Emirati ethnic...
5.
Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in Dubai
Alawadi F, Bashier A, Bin Hussain A, Al-Hashmi N, Bachet F, Hassanein M, et al.
World J Diabetes
. 2023 Sep;
14(8):1259-1270.
PMID: 37664471
Background: Globally, patients with diabetes suffer from increased disease severity and mortality due to coronavirus disease 2019 (COVID-19). Old age, high body mass index (BMI), comorbidities, and complications of diabetes...
6.
Verma S, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, Assaad-Khalil S, et al.
Circulation
. 2023 Mar;
147(16):1251-1255.
PMID: 36877670
No abstract available.
7.
Verma S, Sabbour H, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, et al.
Diabetes Obes Metab
. 2023 Feb;
25(6):1444-1452.
PMID: 36775980
Aim: To investigate the epidemiology and clinical management of patients with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease (eASCVD) or high/very high ASCVD risk, defined by the 2021...
8.
Mamdouh H, Hussain H, Ibrahim G, Alawadi F, Hassanein M, Zarooni A, et al.
BMJ Open
. 2023 Jan;
13(1):e062053.
PMID: 36693685
Objective: To study the prevalence of overweight and obesity and determine the associated risk factors among adults in Dubai. Design And Setting: A cross-sectional survey with a multistage, stratified random...
9.
Alkaabi A, Alkous A, Mahmoud K, AlMansoori A, Elbarazi I, Suliman A, et al.
PLoS One
. 2022 Dec;
17(12):e0278818.
PMID: 36516141
Background: Chronic diseases constitute a major public health problem in the United Arab Emirates (UAE) and are the leading cause of mortality and morbidity. Chronic diseases have been found to...
10.
Hamdy O, Al Sifri S, Hassanein M, Al Dawish M, Al-Dahash R, Alawadi F, et al.
Front Nutr
. 2022 Jun;
9:899393.
PMID: 35769383
Diabetes prevalence is on the rise in the Middle East. In countries of the Gulf region-Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates-prevalence rates are among the...